These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549 [TBL] [Abstract][Full Text] [Related]
4. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408 [TBL] [Abstract][Full Text] [Related]
5. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Spire B; Duran S; Souville M; Leport C; Raffi F; Moatti JP; Soc Sci Med; 2002 May; 54(10):1481-96. PubMed ID: 12061483 [TBL] [Abstract][Full Text] [Related]
6. Alcohol consumption and HIV disease progression: are they related? Samet JH; Horton NJ; Traphagen ET; Lyon SM; Freedberg KA Alcohol Clin Exp Res; 2003 May; 27(5):862-7. PubMed ID: 12766632 [TBL] [Abstract][Full Text] [Related]
7. Health literacy, antiretroviral adherence, and HIV-RNA suppression: a longitudinal perspective. Paasche-Orlow MK; Cheng DM; Palepu A; Meli S; Faber V; Samet JH J Gen Intern Med; 2006 Aug; 21(8):835-40. PubMed ID: 16881943 [TBL] [Abstract][Full Text] [Related]
8. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women. Cruess DG; Minor S; Antoni MH; Millon T J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228 [TBL] [Abstract][Full Text] [Related]
9. Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival. Neblett RC; Hutton HE; Lau B; McCaul ME; Moore RD; Chander G J Womens Health (Larchmt); 2011 Feb; 20(2):279-86. PubMed ID: 21281111 [TBL] [Abstract][Full Text] [Related]
10. At-Risk Alcohol Use is Associated with Antiretroviral Treatment Nonadherence Among Adults Living with HIV/AIDS. Paolillo EW; Gongvatana A; Umlauf A; Letendre SL; Moore DJ Alcohol Clin Exp Res; 2017 Aug; 41(8):1518-1525. PubMed ID: 28679147 [TBL] [Abstract][Full Text] [Related]
11. Alcohol use and non-adherence to antiretroviral therapy in HIV-infected patients in West Africa. Jaquet A; Ekouevi DK; Bashi J; Aboubakrine M; Messou E; Maiga M; Traore HA; Zannou MD; Guehi C; Ba-Gomis FO; Minga A; Allou G; Eholie SP; Bissagnene E; Sasco AJ; Dabis F Addiction; 2010 Aug; 105(8):1416-21. PubMed ID: 20528816 [TBL] [Abstract][Full Text] [Related]
12. Characterizing the Association Between Alcohol and HIV Virologic Failure in a Military Cohort on Antiretroviral Therapy. Deiss RG; Mesner O; Agan BK; Ganesan A; Okulicz JF; Bavaro M; Lalani T; O'Bryan TA; Bebu I; Macalino GE Alcohol Clin Exp Res; 2016 Mar; 40(3):529-35. PubMed ID: 26916712 [TBL] [Abstract][Full Text] [Related]
13. Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: an observational study. Cook RL; Zhou Z; Kelso-Chichetto NE; Janelle J; Morano JP; Somboonwit C; Carter W; Ibanez GE; Ennis N; Cook CL; Cohen RA; Brumback B; Bryant K Addict Sci Clin Pract; 2017 Sep; 12(1):22. PubMed ID: 28950912 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Murphy DA; Belzer M; Durako SJ; Sarr M; Wilson CM; Muenz LR; Arch Pediatr Adolesc Med; 2005 Aug; 159(8):764-70. PubMed ID: 16061785 [TBL] [Abstract][Full Text] [Related]
15. Self-reported alcohol abstinence associated with ART initiation among HIV-infected persons in rural Uganda. Santos GM; Emenyonu NI; Bajunirwe F; Rain Mocello A; Martin JN; Vittinghoff E; Bangsberg DR; Hahn JA Drug Alcohol Depend; 2014 Jan; 134():151-157. PubMed ID: 24169501 [TBL] [Abstract][Full Text] [Related]
16. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903 [TBL] [Abstract][Full Text] [Related]
17. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. Parsons JT; Golub SA; Rosof E; Holder C J Acquir Immune Defic Syndr; 2007 Dec; 46(4):443-50. PubMed ID: 18077833 [TBL] [Abstract][Full Text] [Related]
18. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. Horberg MA; Silverberg MJ; Hurley LB; Towner WJ; Klein DB; Bersoff-Matcha S; Weinberg WG; Antoniskis D; Mogyoros M; Dodge WT; Dobrinich R; Quesenberry CP; Kovach DA J Acquir Immune Defic Syndr; 2008 Mar; 47(3):384-90. PubMed ID: 18091609 [TBL] [Abstract][Full Text] [Related]
19. A cluster randomised controlled trial protocol of an adapted intervention for alcohol use disorders in people living with HIV and AIDS: impact on alcohol use, general functional ability, quality of life and adherence to HAART. Madhombiro M; Dube-Marimbe B; Dube M; Chibanda D; Zunza M; Rusakaniko S; Stewart D; Seedat S BMC Psychiatry; 2017 Jan; 17(1):44. PubMed ID: 28129756 [TBL] [Abstract][Full Text] [Related]